University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 1 of 35
Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa (Virtual)
NCT07579442
Period Pills for Menstrual Regulation: A New Reproductive Health Option
NCT07671989
Efficacy of Written Versus Video Patient Education Materials for Postmastectomy Breast Reconstruction
NCT07602374
Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator
NCT07682311
Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care
NCT07397117
Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center
NCT07519707
Sauna for Offline Connections and Interactive, Authentic Living
NCT07223099
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
NCT07284082
Social Media Support Groups for Adolescent Vaping Cessation
NCT07540780
Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes
NCT07090473
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
NCT07398157
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
NCT07690579
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NCT07506239
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
NCT07145177
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
NCT07226453
Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)
NCT07226440
Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy
NCT07373210
Deep Brain Stimulation for Spinocerebellar Ataxia
NCT07288437
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
NCT07106151
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
NCT07546331
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
NCT06260891
Glaucoma Screening to Enhance At-Risk Californians' Health
NCT06854198
Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
NCT07125235
Strategies for Improving Linkage-to-Care After Eye Disease Screening
NCT06943599
APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
NCT07434635
Prospective Registry of Histotripsy for Soft Tissue Tumors
NCT07470008
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
NCT07418775
Frozen Shoulder and Hormone Replacement Therapy
NCT07278323
Force Sensor Study
NCT07434583
Chronic Infections and Inflammation in ME/CFS: An Observational Study
NCT07227441
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
NCT07220525
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
NCT06853223
Automated Insulin for Management of Intrapartum Glycemia
NCT06883344
Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release
NCT07115901
Optimizing Liver MRI Using Breath-Holding With and Without Oxygen
NCT07135401
Comparison of Microbiome Changes in Healthy Adults Following Ketone Ester Consumption
NCT06954675
Trauma-Informed Care for Smoking Cessation for Pregnancy
NCT07129590
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
NCT07148232
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
NCT07110246
Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP
NCT06975033
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
NCT07121972
Ropivacaine and Fentanyl for Labor Epidural Initiation
NCT07076368
Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
NCT07214467
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
NCT07148245
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
NCT06774027
External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms
NCT07214545
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
NCT07222618
Dopamine and Sensorimotor Function in Stuttering
NCT07215884
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2
NCT07036705
Yoga to Improve Disparities in Cancer Survivorship
NCT07165600
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets.Report a data error.